Induced Pluripotent Stem Cells Market Soars at 12.23% CAGR Between 2019 and 2025

In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.

Los Angeles, United States - September 12, 2019 /MarketersMedia/ —

In a recent research report published by QY Research, titled, “Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025” has analyzed the global induced pluripotent stem cells market. The report is a depth research paper about the various areas of the market, namely, market size, drivers and restrains, segment analysis, regional analysis, key players, and competitive landscape.

In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1243625/global-induced-pluripotent-stem-cells-market

Global Induced Pluripotent Stem Cells Market: Drivers and Restraints

The global induced pluripotent stem cells market is expected to grow with its increasing usage as a regenerative medicine for damaged tissues and diseased organs. This is attributed towards an interesting property of pluripotent stem cells to form various types of adult cells such as neurons, liver, heart, and pancreatic cells. They also can make any cell or tissue combat diseases such as spinal cord injury, diabetes, heart disease, and leukaemia. These cells can be modified to match patient’s genetic makeup. Governments and private sectors are investing heavily in the development of pluripotent stem cells as they enable initial human growth. Its ability to produce customized cells, rejection-proof cells, and tissues for efficacious transplantation is expected to offer lucrative opportunities to the global market for induced pluripotent stem cells.

Increasing interest among scientists to understand and develop stem cells for various ailments is expected to contribute towards the growth of stem cells. Its various roles in clinical applications, research and awareness among people about the benefits of stem cells will boost the market growth during the forecast period.

However, the treatment and reprogramming of cells is a lengthy and costly process. Also the market has certain ethical risks associated with it. Other factors like low efficiency, proliferation rates, potential tumour risk, and incomplete programming can hamper the growth of the global induced pluripotent stem cells market.

Global Induced Pluripotent Stem Cells Market: Segment Analysis

The global induced pluripotent stem cells market is segmented on the basis of type and application. The type segment includes human iPSCs and mouse iPSCs. The application segment includes academic research, drug development and discovery, toxicity screening, regenerative medicine, and others.

Global Induced Pluripotent Stem Cells Market: Regional Analysis

The report analysis various region of the global induced pluripotent stem cells market such as United States, Europe, Asia Pacific (China, India, and Japan), Southeast Asia, Central & South America, and other regions. The market is expected to grow in regions like Asia due to increasing number of research projects. Currently, North America dominates the global market, followed by Europe.

Global Induced Pluripotent Stem Cells Market: Key Players

The key players covered in the report are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc., Fate Therapeutics, Inc., Pluricell Biotech, Cell Inspire Biotechnology, and ReproCELL.

Global Induced Pluripotent Stem Cells Market: Competitive Landscape

Fujifilm Holding Corporation (CDI) is a leading company. They recently announced a collaboration with Axcelead Drug Discovery Partners, Inc. to provide integrated platform for drug discovery solutions. Both the companies will together work towards developing new drug efficacy evaluation methods. They will also develop toxicity testing to meet specific client needs. They will also work towards R&D of iPSC to study ability to differentiate into diverse cells and its infinite reproduction capabilities. As the demand for iPSC is expected to grow further they are planning a standardizing safety tests using differentiated cells.

The increasing competition amongst manufactures is fuelling the need for developmental strategies such as product development, innovative technologies, and joint ventures to boost share in the market. This strategy of Fujifilm Holding Corporation (CDI) is expected to push the company towards significant development in the medical field and set high benchmark for other manufacturers.

Get Complete Report in your Inbox within 24 hours at 3,900 USD https://www.qyresearch.com/settlement/pre/eb11190375650824d3d7695db8b374ce,0,1,Global-Induced-Pluripotent-Stem-Cells-Market-Size-Status-and-Forecast

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.

Contact Info:
Name: Rahul Singh
Email: Send Email
Organization: QY Research, Inc
Address: QY Research, INC. 17890 Castleton, Suite 218, Los Angeles, CA - 91748
Phone: 6264288800
Website: https://www.qyresearch.com/index/detail/1243625/global-induced-pluripotent-stem-cells-market

Source URL: https://marketersmedia.com/induced-pluripotent-stem-cells-market-soars-at-1223-cagr-between-2019-and-2025/88918267

Source: MarketersMedia

Release ID: 88918267

More Press Releases

The Latest: British PM questions Thomas Cook bosses' pay

Sep 23, 2019

LONDON — The Latest on the collapse of British tour company Thomas Cook (all times local): 6 p.m. Prime Minister Boris Johnson says a "huge effort" is underway to bring home British tourists and passengers stranded by the sudden financial collapse of travel company Thomas Cook. He adds Monday that steps needed to be taken so "you don't end up with a situation where the taxpayer, where the state is having to step in and bring people home." Johnson asks "whether it's right that the directors and the board should pay themselves large sums when a company can go down...

Stocks edge higher; S&P 500 heads for another week of gains

Sep 23, 2019

NEW YORK — U.S. stocks edged higher in early trading on Friday as most sectors of the market posted small gains. The S&P 500 rose 0.3% to 3,014 and is within 12 points of all-time high. The index is headed for a fourth straight weekly gain, even after some volatility during the week caused by volatile oil prices and the Federal Reserve's latest interest rate cut. Health care and technology stocks are leading the gains. Big pharmaceutical companies, including Pfizer and Merck were among the biggest winners. Tech giant Apple also made solid gains. Bank stocks rose as bond yields...

Japan central bank stands pat after Fed rate cut

Sep 23, 2019

TOKYO — Japan's central bank opted Thursday to keep its monetary policy unchanged despite the growing signs of trouble that prompted the Federal Reserve to cut its benchmark rate. The Bank of Japan said in its policy statement that exports, industrial output and business sentiment had been affected by the slowdown in overseas markets. The China-U.S. tariff war has pummeled Japan's exports. But the BOJ said strong corporate profits were supporting business investment. The Federal Reserve reduced its key short-term rate — which influences many consumer and business loans — by a quarter-point to a range of 1.75%-2% on Wednesday....

Oil price drops on hopes for quick recovery of Saudi output

Sep 23, 2019

LONDON — The price of oil is falling back further after the Saudi government said half of production that was knocked out by an attack over the weekend had already had been restored. Benchmark U.S. crude was down 42 cents to $58.92 per barrel in electronic trading Wednesday. The contract fell $3.56 on Tuesday. Brent crude, the international benchmark, fell 27 cents to $64.28 per barrel in London, having dropped $4.47 the previous session. The attack on oil producer Saudi Aramco's processing facility in Abqaiq saw crude surge more than 14% on Monday, about as much as it did when...

Stocks mixed, oil down as markets await news on Saudi plant

Sep 23, 2019

BANGKOK — World shares were mixed on Tuesday and oil prices eased back pending updates on restoring output at a Saudi Aramco oil processing plant damaged by an attack over the weekend. Chinese benchmarks led declines in Asia after the credit ratings agency Moody's downgraded Hong Kong, citing its recent political turmoil. Germany's DAX lost 0.2% to 12,362 after the ZEW index showed a drop in investor confidence in current economic conditions, pointing to the possibility of a brief recession, but sees a pick-up later in the year. The CAC 40 in Paris added 0.1% to 5,607 and the FTSE...

Subscribe to our newsletter!

Your Name

Your Email Address